|
| |
| Gaviscon, Liquidum - 200 ml | | 42237019 | | NOVARTIS CONSUMER HEALTH SCHWEIZ AG | | Gaviscon, Liquidum | | 09.07.1980 | | | | | | | Antacida, andere Kombinationen (A02AX) | | | | WHO-DDD | | | | | | 200 ml | | | | | | D | | | | Nein | | | | | | PI | | PA | | | | k.A. | | 12.90 | | FB | | | | 7680422370191 | | | | | | |
| | Zusammensetzung | | | | Packungsbestandteile | | Suspension (oral) | | | | Wirkstoffe | Stärke |
|---|
| Aluminii Oxidum Hydricum | 200 mg | | Calcii Carbonas | 150 mg | | Natrii Alginas | 500 mg | | Natrii Hydrogenocarbonas | 170 mg |
|
| | Quelle | | | |
|
|
|
